Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 83%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,483
Total Claims
$684K
Drug Cost
1,202
Beneficiaries
$569
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-50%
Opioid rate vs peers
1.3% vs 2.6% avg
-47%
Cost per patient vs peers
$569 vs $1,068 avg
+2%
Brand preference vs peers
9.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.3%
Opioid Rate
162
Opioid Claims
$898
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,135 claims · $511K
Generic: 11,274 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 59 | $73K |
| Empagliflozin | 57 | $62K |
| Sitagliptin Phosphate | 74 | $61K |
| Apixaban | 60 | $43K |
| Linagliptin | 19 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 60 | $25K |
| Dulaglutide | 15 | $25K |
| Tirzepatide | 17 | $19K |
| Fluticasone/Umeclidin/Vilanter | 16 | $15K |
| Dapagliflozin Propanediol | 17 | $14K |
| Varicella-Zoster Ge/As01b/Pf | 54 | $11K |
| Mesalamine | 12 | $11K |
| Mirabegron | 22 | $10K |
| Fluticasone/Vilanterol | 17 | $7,208 |
| Linaclotide | 13 | $7,124 |
Prescribing Profile
Patient Profile
73
Avg Age
55%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About